PDS Biotechnology Completes Merger with Edge Therapeutics Shares of Combined Company to Commence Trading on Nasdaq Capital Market under New Symbol “PDSB” on March 18, 2019 PRINCETON, N.J., March 18, 2019 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (“PDS...
Neurana Pharmaceuticals Announces First Patient Enrolled in the STAR Study Neurana Pharmaceuticals Announces First Patient Enrolled in the “STAR Study,” a Phase 2 Dose Ranging Study of Tolperisone in Acute Muscle Spasms of the Back SAN DIEGO, February 4th, 2019...
PRINCIPIA BIOPHARMA ANNOUNCES POSITIVE DATA FROM PHASE 2 PEMPHIGUS VULGARIS TRIAL AT 2019 AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING IN LATE-BREAKING PRESENTATION Reached primary endpoint of Control of Disease Activity at four weeks in 54 percent of patients on...
Recent Comments